Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Patent
1986-08-26
1988-03-15
Robinson, Douglas W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
514900, A61K 31195
Patent
active
047313803
ABSTRACT:
A method is disclosed for the prevention and treatment of periodontal disease and alveolar bone loss by administering an effective amount of tolrestat to a human subject.
REFERENCES:
patent: 4560794 (1985-12-01), Foster
patent: 4562286 (1985-12-01), Foster
patent: 4568693 (1986-02-01), Sestanj et al.
patent: 4590010 (1986-05-01), Ramachandran et al.
patent: 4590290 (1986-05-01), Bright
patent: 4604406 (1986-08-01), Bellini et al.
patent: 4672058 (1987-06-01), Bellini et al.
patent: 4672059 (1987-06-01), Bellini et al.
American Home Products Corporation (Del.)
Robinson Douglas W.
Routh John W.
LandOfFree
Tolerstat as an agent for diabetic periodontitis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tolerstat as an agent for diabetic periodontitis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tolerstat as an agent for diabetic periodontitis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1926740